""

Colorectal cancer

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Surgical Study

Title: Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients
Phase: N/A
Contact: Dr.sc.hum Biljana Gigic / (Kontaktperson)
Clinical Investigator: Prof. Dr. Alexis Ulrich
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03030508
EudraCT-Number: Keine Angabe. Nicht-interventionelle Studien oder Studien, die nicht unter das Arzneimittelgesetz fallen, besitzen keine EudraCT-Nummer.

Radiotherapy Study

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: A Phase 3b Randomized Clinical Trial of Nivolumab alone, Nivolumab in Combination with Ipilimumab, or an Investigator’s Choice Chemotherapy in Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Metastatic Colore
Phase: III
Contact: Julia Weck / (Study Nurse)
Clinical Investigator: PD Dr. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04008030
EudraCT-Number: siehe EU klinisches Studienregister 2018-000040-26

Metastatic Disease: Follow-Up Care

Title: A Randomized Phase-2 Study of Trabectedin/Olaparib Compared to Physician's Choice in Subjects With Previously Treated Advanced or Recurrent Solid Tumors Harboring DNA Repair Deficiencies
Phase: II
Contact: Barbara Stöhr / (Study Nurse)
Clinical Investigator: Prof. Dr. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03127215
EudraCT-Number: siehe EU klinisches Studienregister 2017-001755-31

Others

There are currently no studies available